Rutherford Health plc is at the vanguard of advancing cancer care.

Developing and building a network of oncology centres across the UK known as the Rutherford Cancer Centres, offering a comprehensive range of cancer treatments to patients.

We plan to open a network of centres in the next few years and the first centre in Newport, South Wales, was the first in the UK to offer high energy proton therapy. In addition, each centre also offers radiotherapy, chemotherapy, immunotherapy, diagnostic imaging and supportive care services.

As well as the Rutherford Cancer Centre South Wales, Rutherford Health plc (formerly known as Proton Partners International Limited) has opened two further centres – the Rutherford Cancer Centre North East in Northumberland and the Rutherford Cancer Centre Thames Valley in Reading, with proton therapy now available in both. A fourth site is under construction in Liverpool, the Rutherford Cancer Centre North West.

Rutherford Health plc has partnered with world-leading healthcare technology providers to equip each centre with the very latest and innovative technology, including IBA, Philips and Elekta.

Rutherford Health plc was founded in 2015 by Mike Moran and UK and international cancer experts, including Professor Edward Karol Sikora, former head of the World Health Organisation’s cancer programme. Initial investors include the Wales Life Sciences Investment Fund managed by Professor Sir Chris Evans, the leading life sciences entrepreneur, and the Woodford Patient Capital Trust.


CORONAVIRUS ADVICE - For Rutherford Cancer Centre patients

At Rutherford Health Plc, the health and well-being of our patients, colleagues and partners is of utmost importance. We are maintaining a safe environment within all Rutherford Cancer Centre sites across the Rutherford Health Plc network by carrying out deep cleaning and encouraging everyone to wash their hands more often. Plans are being put in to place to maintain treatments and we will be communicating this to patients and their families. Rutherford Health Plc will continue to ensure we navigate these challenging circumstances with everyone's health and well-being in mind, and we encourage everyone to take these vital steps to stop the spread of the Coronavirus (COVID-19). 

Further information 

Rutherford Health Plc will continue to provide guidance and regular updates for patients, and would like to encourage all Rutherford patients and families to visit the NHS England or NHS Wales websites for the most recent advice regarding the Coronavirus. If you require any further information about the Coronavirus in relation to your treatment, please call your relevant centre and speak to a member of our team:

  • South Wales - Newport: 01633 740 005
  • Thames Valley - Reading: 01182 075 610
  • North East - Northumberland: 01670 339 650

iip livingwage iso9001